← back to search

Markus Fischer

University Hospital Heidelberg · DE
Area of research
Computational Theory and Mathematics · Molecular Biology
Research interest
Research interests include Membrane, Chemistry, Small molecule, Lipid bilayer, Computer science, and Web server.
h-index
citations
70
works
5
NIH funding
primary concept
email

Recent publications

The small-molecule kinase inhibitor ceritinib, unlike imatinib, causes a significant disturbance of lipid membrane integrity: A combined experimental and MD study
Chemistry and Physics of Lipids 2023cited by 5position: firstdoi
<tt>ProteinPrompt</tt> : a webserver for predicting protein–protein interactions
Bioinformatics Advances 2022cited by 30position: middledoi
Drug–Membrane Interactions: Effects of Virus-Specific RNA-Dependent RNA Polymerase Inhibitors Remdesivir and Favipiravir on the Structure of Lipid Bilayers
Biochemistry 2022cited by 9position: firstdoi
Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes
Pharmaceuticals 2021cited by 7position: middledoi
Interaction of the small-molecule kinase inhibitors tofacitinib and lapatinib with membranes
Biochimica et Biophysica Acta (BBA) - Biomembranes 2020cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Meike Luck · Humboldt-Universität zu Berlin4 papers (2020–2023)Peter Müller · Humboldt-Universität zu Berlin4 papers (2020–2023) · 4 papers (2020–2023) · 1 papers (2022–2022) · 1 papers (2022–2022)Mohammad Bashawat · Humboldt-Universität zu Berlin1 papers (2023–2023)Kai Ludwig · Freie Universität Berlin1 papers (2023–2023)René Staritzbichler · Johannes Gutenberg University Mainz1 papers (2022–2022) · 1 papers (2023–2023)Daniel Huster · Telstra (Australia)1 papers (2020–2020)Ivan Haralampiev · Humboldt-Universität zu Berlin1 papers (2020–2020)Maximilian Werle · Humboldt-Universität zu Berlin1 papers (2021–2021) · 1 papers (2022–2022) · 1 papers (2020–2020)Peter W. Hildebrand · Leipzig University1 papers (2022–2022)Santiago Di Lella · Universidad de Buenos Aires1 papers (2020–2020)Tobias Abel · Allogene Therapeutics (United States)1 papers (2020–2020)M. Werle · Humboldt-Universität zu Berlin1 papers (2023–2023)